| 期刊簡介 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | VASCULAR PHARMACOLOGY LetPub Score 7.4
50 ratings
Rate
Reputation 8.6 Influence 6.2 Speed 9.2 | ||||||||||||||||||||||||
| 期刊簡稱 | VASC PHARMACOL | ||||||||||||||||||||||||
| ISSN | 1537-1891 | ||||||||||||||||||||||||
| E-ISSN | 1879-3649 | ||||||||||||||||||||||||
| h-index | 86 | ||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||
| 自引率 (2023-2024) | 2.90%自引率趨勢 | ||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||
| 官方網站 | http://www.journals.elsevier.com/vascular-pharmacology/ | ||||||||||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/VPH | ||||||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||||||
| 出版商 | Elsevier Inc. | ||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||||||
| 創刊年 | 2002 | ||||||||||||||||||||||||
| 每年文章數 | 68每年文章數趨勢 | ||||||||||||||||||||||||
| 黃金OA百分比 | 27.45% | ||||||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1537-1891%5BISSN%5D | ||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||
| 在線文章發布時間 | 來自Elsevier的數據: Average 16 Week(s) | ||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [VASCULAR PHARMACOLOGY] 的評論 | 撰寫評論 |
| 作者: Nemo711 領域: 医学 審稿時間: 8.0 month(s) 結果: 拒稿 撰寫評論 |
2022-06-29 16:30:52 評論於 Extremely slow, asked multiple times in the middle, but they claimed to be unable to find any reviewers. As a result, we found 5-6 reviewers in the end, but only one of them provided substantial feedback. Two were very good, while the other two simply suggested minor revisions. Ultimately, the editor rejected the submission outright. Be cautious when considering submitting to them!  (0) 讚！ | Nemo711  |
| 作者: 卢子凰 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-06-23 21:24:00 評論於 It took two months for the review, and it was not too difficult. The comments given by the reviewers were nice. One week after minor revision, it was accepted. Generally speaking, if the experiments are enough, there will be no big problems. (1) 讚！ | 卢子凰 |
| 作者: 道法自然 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-11-28 19:17:31 評論於 This journal only publishes a small number of papers each year. Has a high standard for pharmacology. The quality is fairly good. The first round of review takes about 2 months. (4) 讚！ | 道法自然 |
| 作者: 水荷酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-28 18:34:15 評論於 Review Speed: 2.0 Experience Sharing: This journal has a low annual publication volume with a high requirement for pharmacology, but the quality is good. The first review process takes around 2 months (0) 讚！ | 水荷酱吖 |
| 作者: 墟散高芬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-11-28 10:10:13 評論於 This magazine has a low annual publication volume, with high requirements for pharmacology and decent quality. The first review cycle is around 2 months (0) 讚！ | 墟散高芬 |
| 作者: 北陆梧桐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2018-10-08 10:28:39 評論於 Review speed: 12.0 | Submission acceptance rate: 50.0 Experience sharing: This journal is really slow. The first review took two months, and there has been no change in three months for the second review. It's too time-consuming (0) 讚！ | 北陆梧桐 |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2013-07-01 10:58:57 評論於 We are only 2 points behind, hopefully we can catch up next year (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
